Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial

• Marat Fudim,
• Daniel M. Wojdyla,
• John H. Alexander,
• Shaun G. Goodman,
• Roxana Mehran,
• Stephan Windecker,
• Ronald Aronson,
• Dragos Vinereanu,
• Sigrun Halvorsen,
• M. Cecilia Bahit,
• Christopher B. Granger,
• Renato D. Lopes

Affiliations

Marat Fudim

Duke Clinical Research Institute Duke University School of Medicine Durham NC

Daniel M. Wojdyla

Duke Clinical Research Institute Duke University School of Medicine Durham NC

John H. Alexander

Duke Clinical Research Institute Duke University School of Medicine Durham NC

Shaun G. Goodman

Canadian VIGOUR Centre University of Alberta Edmonton Canada

Roxana Mehran

Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai, and Cardiovascular Research Foundation New York NY

Stephan Windecker

Bern University Hospital Inselspital University of Bern Switzerland

Ronald Aronson

Bristol Myers Squibb Lawrenceville NJ

Dragos Vinereanu

University of Medicine and Pharmacy Carol DavilaUniversity and Emergency Hospital of Bucharest Bucharest Romania

Sigrun Halvorsen

Institute of Clinical Medicine University of Oslo Norway

M. Cecilia Bahit

Fundación INECOINECO Neurociencias Oroño Rosario, Santa Fe Argentina

Christopher B. Granger

Duke Clinical Research Institute Duke University School of Medicine Durham NC

Renato D. Lopes

Duke Clinical Research Institute Duke University School of Medicine Durham NC